Broome Oncology — Johnson City, New York

Broome Oncology is a clinical research site located in Johnson City, New York, United States 13790.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Broome Oncology has participated in 35 clinical trials with 7 currently active.

Therapeutic areas: Multiple Myeloma, Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer.

Sponsors: Celgene, Gilead Sciences, Infinity Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Johnson City

Browse all research sites in New York · View every site in Johnson City

• United Health Services Hospital
• United Health Service Hospitals, Office of Clinical Trials
• United Health Services Hospitals
• Wilson Hospital Breast Center
• Research Site
• GSK Investigational Site
• United Health Services
• United Medical Associates
• Pfizer Investigational Site
• Southern New York Neurosurgical Group
• Duramed Investigational Site

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Broome Oncology?

Broome Oncology has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Broome Oncology conducted?

Broome Oncology has 35 clinical trials on record, with 7 currently active. Their work covers Multiple Myeloma, Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer.

Is Broome Oncology accredited by Crixeo Clinical Trials?

Broome Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Broome Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.